Dr. Ioannis Tarnanas, Ph.D. | LinkedIn
Greek Researcher Receives Top European Innovation Award
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Loop | Ioannis Tarnanas
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas - Worldwebforum
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Evaluation of Three State-of-the-Art Classifiers for Recognition of Activities of Daily Living from Smart Home Ambient Data – topic of research paper in Medical engineering. Download scholarly article PDF and read for
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas - Worldwebforum
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas | Nature Portfolio Health Community
Stream Ioannis Tarnanas: Atlantic Equity for Equity in Brain Health by Atlantic Fellows | Listen online for free on SoundCloud
Interviews - Trinity Development & Alumni - Trinity College Dublin
Ioannis Tarnanas - Worldwebforum
